L-Allylglycine是一种谷氨酸脱羧酶（GAD）抑制剂，可减少大脑中GABA的生物合成。
Cas No.:16338-48-0
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
L-Allylglycine is an inhibitor for glutamate decarboxylase (GAD) that reduces the GABA biosynthesis in the brain [1]. L-Allylglycine leads to a decrease in SAM-DC activity as well as in the levels of spermidine and spermine, and affect the acetylation of putrescine and spermidine in mouse brain[2]. L-Allylglycine has been widely used to induce seizures in animals in order to study changes in brain function[3].
In vivo, L-Allylglycine treatment via an intravenous injection of 100mg/kg dose for 2 hours caused photosensitive epilepsy in the baboons, resulting in symptoms such as vomiting, persistent vertical nystagmus and intermittent extensor muscle spasms[4]. L-Allylglycine treatment (1.2mmol/kg; i.p.) induced convulsions within 90min in rats, characterized by violent running followed by tonic flexion and extension[5]. Injecting L-allylglycine (25μg) into the posterior hypothalamus of rats for 90min resulted in a decrease in local GABA levels and caused an increase in heart rate and blood pressure[6]. After injecting a single dose of 5μg/0.2μl of L-Allylglycine into the ventral regions of the periaqueductal gray (vPAG) of rats for 45 minutes, the rats exhibited intense hyperactivity, including jumping and standing on the hind legs[7].
References:
[1] Beart P M, Bilal K. Allylglycine: intranigral effects and reappraisal of actions on the GABA system[J]. Biochemical Pharmacology, 1979, 28(4): 449-454.
[2] Ortiz J G, Giacobini E, Schmidt-Glenewinkel T. Allylglycine affects acetylation of putrescine and spermidine in mouse brain[J]. Neuropharmacology, 1983, 22(10): 1237-1239.
[3] Chapman A G, Westerberg E, Premachandra M, et al. Changes in regional neurotransmitter amino acid levels in rat brain during seizures induced by l‐allylglycine, bicuculline, and kainic acid[J]. Journal of neurochemistry, 1984, 43(1): 62-70.
[4] Meldrum B S, Menini C, Naquet R, et al. Proconvulsant, convulsant and other actions of the D-and L-stereoisomers of allylglycine in the photosensitive baboon, Papio papio[J]. Electroencephalography and Clinical Neurophysiology, 1979, 47(4): 383-395.
[5] Horton R W, Chapman A G, Meldrum B S. Regional changes in cerebral GABA concentration and convulsions produced by D and by L‐allylglycine[J]. Journal of neurochemistry, 1978, 30(6): 1501-1504.
[6] Abshire V M, Hankins K D, Roehr K E, et al. Injection of L-allylglycine into the posterior hypothalamus in rats causes decreases in local GABA which correlate with increases in heart rate[J]. Neuropharmacology, 1988, 27(11): 1171-1177.
[7] Cunha J M, Zanoveli J M, Ledvinka-Filho E, et al. L-allylglycine dissociates the neural substrates of fear in the periaqueductal gray of rats[J]. Brain research bulletin, 2010, 81(4-5): 416-423.
L-Allylglycine是一种谷氨酸脱羧酶（GAD）抑制剂，可减少大脑中GABA的生物合成[1]。L-Allylglycine导致小鼠脑中SAM-DC活性以及亚精胺和精胺水平的下降，并影响腐胺和亚精胺的乙酰化[2]。L-Allylglycine已被广泛用于在动物中诱导癫痫发作，以研究脑功能变化[3]。
在体内，静脉注射100mg/kg剂量的L-Allylglycine 2小时，导致狒狒出现光敏性癫痫，引起呕吐、持续性垂直眼震和间歇性伸肌痉挛等症状[4]。L-Allylglycine（1.2mmol/kg；i.p.）在90分钟内诱导大鼠出现惊厥，表现为剧烈跑动后伴随强直性屈曲和伸展[5]。向大鼠下丘脑后部注射L-Allylglycine（25μg）90分钟，导致局部GABA水平下降，并引起心率和血压升高[6]。单次向大鼠导水管周围灰质腹侧区（vPAG）注射5μg/0.2μl的L-Allylglycine（45分钟），大鼠表现出强烈的过度活跃，包括跳跃和用后腿站立[7]。
| Animal experiment [1]: | |
Animal models | Male Wistar rats |
Preparation Method | Male Wistar rats weighing 250-300g were housed in a temperature-controlled (22±1°C) room maintained on a 12/12h light/dark cycle (lights on 07:00-19:00). The rats were housed in groups of five per cage (40cm×30cm×25cm) and given free access to food and water throughout the experiment. Rats were anaesthetized with tribromoethanol (250mg/kg; i.p.) and placed in a stereotaxic frame. Each rat was implanted with a stainless-steel guide cannula made from hypodermic needles (30 gauge) aimed at the vPAG. Each rat received only one injection of either saline or L-Allylglycine (5μg/0.2μl), and rats were placed in the middle of the arena and left undisturbed for a 45min period of free exploration of the open field. Rat behavior was recorded by a video camera positioned above the arena. |
Dosage form | 5μg/0.2μl for once; vPAG injection |
Applications | L-Allylglycine treatment caused the rats to exhibit intense hyperactivity, including jumping or standing on hind legs. |
References: | |
| Cas No. | 16338-48-0 | SDF | |
| 别名 | (S)-(-)-2-氨基-4-戊烯酸,L-Allylglycine | ||
| Canonical SMILES | OC([C@@H](N)CC=C)=O | ||
| 分子式 | C5H9NO2 | 分子量 | 115.1 |
| 溶解度 | Ethanol: Insoluble,PBS (pH 7.2): 10 mg/ml | 储存条件 | Store at RT |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 8.6881 mL | 43.4405 mL | 86.881 mL |
| 5 mM | 1.7376 mL | 8.6881 mL | 17.3762 mL |
| 10 mM | 868.8 μL | 4.344 mL | 8.6881 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00% Appearance: A solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet